絞り込み

16530

広告

Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators.

著者 Matei AE , Beyer C , Györfi AH , Soare A , Chen CW , Dees C , Bergmann C , Ramming A , Friebe A , Hofmann F , Distler O , Schett G , Distler JHW
Ann Rheum Dis.2018 Jan 08 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (26view , 0users)

Full Text Sources

Miscellaneous

Stimulators of soluble guanylate cyclase (sGC) are currently investigated in clinical trials for the treatment of fibrosis in systemic sclerosis (SSc). In this study, we aim to investigate the role of protein kinases G (PKG) as downstream mediators of sGC-cyclic guanosine monophosphate (cGMP) in SSc.
PMID: 29311148 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード